In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter?
article has not abstract
Vyšlo v časopise:
In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter?. PLoS Med 5(1): e4. doi:10.1371/journal.pmed.0050004
Kategorie:
The Debate
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.0050004
Souhrn
article has not abstract
Zdroje
1. [No authors listed]
1996
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.
Lancet
348
1329
1339
2. FurukawaTAStreinerDLHoriS
2000
Discrepancies among megatrials.
J Clin Epidemiol
53
1193
1199
3. MontoriVMPermanyer-MiraldaGFerreira-GonzalezIBusseJWPacheco-HuergoV
2005
Validity of composite end points in clinical trials.
BMJ
330
594
596
4. ClarkeMChalmersI
1998
Discussion sections in reports of controlled trials published in general medical journals: islands in search of continents.
JAMA
280
280
282
5. HalpernSDKarlawishJHBerlinJA
2002
The continuing unethical conduct of underpowered clinical trials.
JAMA
288
358
362
6. AltmanDGBlandJM
1995
Absence of evidence is not evidence of absence.
BMJ
311
485
7. MooreRAGavaghanDTramèrMRCollinsSLMcQuayHJ
1998
Size is everything—large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects.
Pain
78
217
220
8. DickersinKMinYI
1993
NIH clinical trials and publication bias.
Online J Curr Clin Trials
Doc No. 50
9. AltmanDG
1980
Statistics and ethics in medical research, III: how large a sample.
BMJ
281
1336
1338
10. MuellerPSMontoriVMBasslerDKoenigBAGuyattGH
2007
Ethical issues in stopping randomized trials early because of apparent benefit.
Ann Intern Med
146
878
881
11. MontoriVMDevereauxPJAdhikariNKBurnsKEEggertCH
2005
Randomized trials stopped early for benefit: a systematic review.
JAMA
294
2203
2209
12. SnowdonCElbourneDRGarciaJCampbellMKEntwistleVA
2006
Financial considerations in the conduct of multi-centre randomised controlled trials: evidence from a qualitative study.
Trials
7
34
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2008 Číslo 1
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Model-Based Insights into Multi-Host Transmission and Control of Schistosomiasis
- New Insights into Impaired Muscle Glycogen Synthesis
- Targeting PDGF Signaling in Carcinoma-Associated Fibroblasts Controls Cervical Cancer in Mouse Model
- The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States